L3Harris is a top defense contractor, and trades at a forward price-to-earnings multiple of 15. That's not as deeply discounted as Pfizer ... gains down the road. David Jagielski has no position ...

Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads significantly. Read my MRNA analysis.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

The two blockbusters Novo Nordisk medicines are among 15 additional drugs whose prices Medicare will be allowed to negotiate ...

As a consequence of Pfizer’s innovation, the price of citric acid tumbled over ... Pfizer seemed unable to allay the concerns of prime minister David Cameron and business secretary Vince Cable.

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Price/Fair Value: 0.46 Morningstar Uncertainty ... Drug Manufacturers—General A household name among drug manufacturers, Pfizer’s stock is currently trading at a 37% discount to its fair ...

The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

Companies seeking to benefit from campaign promises to cut regulations and taxes are ditching diversity and climate initiatives; ‘EVERYBODY WANTS TO BE MY FRIEND!!!’ ...

Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...

The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs than it ...